从对恶性组织细胞病的认识过程看医学创新

On Medical Innovation in Term of the Malignant Histocytosis

恶性组织细胞病由英国的两位病理学家于1939年提出并成为一种教科书上的疾病。但世界卫生组织在2000年的最新分类标准中将这种疾病名称取消,因为经过免疫组织化学等技术复查发现,以前诊断过的恶性组织细胞实际上是淋巴细胞或是间变性淋巴细胞。围绕这一案例,对医学科技创新与失败,医学科技创新的方法论,医学科技创新的艰巨性,医学科技创新与仪器手段,医学科技创新的起点及中国医学科技创新的现状等进行了论述。

Malignant histocytosis(MH) was firstly identified and defined as an independent kind of disease in 1939 and got received world-widely, then appeared in the medical textbook. But in 2000, the World Health Organization deleted the designation of MH since the new findings indicated that the cells of MH have the absolutely same markers as the lymphocytic cells.To try to discuss something concerning about scientific creativity in the process of medical research ,focusing on how to face failure of research, methodology in research, how to start with creative research and what is going on in China in term of medical research currently.